Hank Mansbach
2023
In 2023, Hank Mansbach earned a total compensation of $2.5M as Chief Medical Officer at 89bio, a 66% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $243,900 |
---|---|
Option Awards | $1,368,516 |
Salary | $483,000 |
Stock Awards | $441,000 |
Other | $5,971 |
Total | $2,542,387 |
Mansbach received $1.4M in option awards, accounting for 54% of the total pay in 2023.
Mansbach also received $243.9K in non-equity incentive plan, $483K in salary, $441K in stock awards and $6K in other compensation.
Rankings
In 2023, Hank Mansbach's compensation ranked 379th out of 2,940 executives tracked by ExecPay. In other words, Mansbach earned more than 87.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 379 | 87th |
Manufacturing | 217 | 87th |
Chemicals And Allied Products | 151 | 83rd |
Drugs | 148 | 83rd |
Pharmaceutical Preparations | 90 | 86th |
Mansbach's colleagues
We found two more compensation records of executives who worked with Hank Mansbach at 89bio in 2023.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020